Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ESCMID COVID-19 living guidelines: drug treatment and clinical management
Michele Bartoletti, Özlem Kurt Azap, Aleksandra Barać, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 222-238
Open Access | Times Cited: 139

Showing 1-25 of 139 citing articles:

Safety of ceftobiprole in patients with impaired renal, hepatic or immune function: a multinational retrospective hospital chart review (RETRACE study)
Francisco Javier Membrillo de Novales, Marco Falcone, Álex Soriano, et al.
International Journal of Antimicrobial Agents (2025), pp. 107450-107450
Open Access | Times Cited: 1
Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach
Rafael Dal‐Ré, Sören L. Becker, Emmanuel Bottieau, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 8, pp. e231-e238
Open Access | Times Cited: 60
Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions
Matthias Egger, Linda Bussini, Martin Hoenigl, et al.
Journal of Fungi (2022) Vol. 8, Iss. 4, pp. 390-390
Open Access | Times Cited: 40
The intersection of obesity and (long) COVID-19: Hypoxia, thrombotic inflammation, and vascular endothelial injury
Mengqi Xiang, Xiaoming Wu, Haijiao Jing, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 38
Outcome of early treatment of SARS‐CoV‐2 infection in patients with haematological disorders
Małgorzata Mikulska, Diletta Testi, Chiara Russo, et al.
British Journal of Haematology (2023) Vol. 201, Iss. 4, pp. 628-639
Open Access | Times Cited: 30
Drug treatment of COVID-19 infection
Grace Lui, Giovanni Guaraldi
Current Opinion in Pulmonary Medicine (2023) Vol. 29, Iss. 3, pp. 174-183
Open Access | Times Cited: 30
Remdesivir: A Review in COVID-19
Hannah A. Blair
Drugs (2023) Vol. 83, Iss. 13, pp. 1215-1237
Open Access | Times Cited: 28
Risk factors and effect on mortality of superinfections in a newly established COVID-19 respiratory sub-intensive care unit at University Hospital in Rome
Alessandra Iacovelli, Alessandra Oliva, Guido Siccardi, et al.
BMC Pulmonary Medicine (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 22
Systemic Inflammation after Aneurysmal Subarachnoid Hemorrhage
Chang-Zhang Chai, Ue-Cheung Ho, Lu‐Ting Kuo
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10943-10943
Open Access | Times Cited: 22
Efficacy and safety of antiviral plus anti-spike monoclonal antibody combination therapy vs. monotherapy for high-risk immunocompromised patients with mild-to-moderate SARS-CoV2 infection during the Omicron era: A prospective cohort study
Jorge Calderón‐Parra, Andrea Gutiérrez-Villanueva, Gerard Ronda-Roca, et al.
International Journal of Antimicrobial Agents (2024) Vol. 63, Iss. 3, pp. 107095-107095
Open Access | Times Cited: 8
Adverse events related to drug–drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era: a systematic review
Valeria Conti, Nicola Bertini, Rosaria Ricciardi, et al.
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 4, pp. 275-292
Closed Access | Times Cited: 7
Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID‐19
Jheng‐Yan Wu, Mei‐Yuan Liu, Tinghui Liu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Open Access | Times Cited: 17
Treatment of COVID-19 during the Acute Phase in Hospitalized Patients Decreases Post-Acute Sequelae of COVID-19
Diana Badenes Bonet, Oswaldo Antonio Caguana Vélez, Xavier Durán, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 12, pp. 4158-4158
Open Access | Times Cited: 15
Efficacy and Safety of Corticosteroid Therapy for Community-Acquired Pneumonia: A Meta-Analysis and Meta-Regression of Randomized, Controlled Trials
Felix Bergmann, Lena Pracher, Rebecca Sawodny, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 12, pp. 1704-1713
Closed Access | Times Cited: 15
Patient Experiences Navigating Care Coordination For Long COVID: A Qualitative Study
Sarah R. MacEwan, Saurabh Rahurkar, Will L. Tarver, et al.
Journal of General Internal Medicine (2024) Vol. 39, Iss. 8, pp. 1294-1300
Open Access | Times Cited: 5
Efficacy of different doses of corticosteroids in treating severe COVID-19 pneumonia
Ge zhang, Lin Su, Wenwen Wu, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Clostridioides Difficile: A Concise Review of Best Practices and Updates
Abdelrahman Yakout, Yan Bi, Dana M. Harris
Journal of Primary Care & Community Health (2024) Vol. 15
Open Access | Times Cited: 5
Therapeutic Versus Non‐Therapeutic Dose Anticoagulation in COVID‐19 Infection: A Systematic Review and Meta‐analysis of Randomised Controlled Trials
Sushil Selvarajan, Jisha Sara John, Prathap Tharyan, et al.
eJHaem (2025) Vol. 6, Iss. 1
Open Access
The Effect of Antibiotic Use on Intensive Care Unit Admission and Mortality in Inpatients with COVID-19 Diagnosis
Taliha Karakök, Ahmet Doğan, Onur Acar
Düzce Tıp Fakültesi Dergisi (2025), Iss. Early Access
Open Access
Best practices for guideline development in Critical Care
Letícia Kawano-Dourado, Tyler Pitre, Dena Zeraatkar, et al.
Critical Care Science (2025) Vol. 37
Closed Access
Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study
Antoní Torres, Ana Motos, Catia Cillóniz, et al.
Intensive Care Medicine (2022) Vol. 48, Iss. 7, pp. 850-864
Open Access | Times Cited: 24
COVID-19 as Another Trigger for HBV Reactivation: Clinical Case and Review of Literature
Caterina Sagnelli, Laura Montella, Pierantonio Grimaldi, et al.
Pathogens (2022) Vol. 11, Iss. 7, pp. 816-816
Open Access | Times Cited: 24
Bacterial Ventilator-Associated Pneumonia in COVID-19 Patients: Data from the Second and Third Waves of the Pandemic
Alessandro Russo, Vincenzo Olivadese, Enrico Maria Trecarichi, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2279-2279
Open Access | Times Cited: 22
Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
John W. Eikelboom, Sanjit S. Jolly, Emilie P. Belley‐Côté, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 12, pp. 1169-1177
Open Access | Times Cited: 22
Efficacy and Safety of Favipiravir in Treating COVID-19 Patients: A Meta-Analysis of Randomized Control Trials
Saima Batool, Kiranmayi Vuthaluru, Amna Hassan, et al.
Cureus (2023)
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top